KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION;주식회사 셀버틱스;고려대학교 산학협력단;CELLVERTICS
发明人:
SEO, Hong Seog,서홍석,LEE, Yong Jik,이용직,SONG, Jong-Suk,송종석,EOM, Young Sub,엄영섭
申请号：
KRKR2020/000479
公开号：
WO2020/145728A1
申请日:
2020.01.10
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition for treatment or prevention of diabetic cataract, the pharmaceutical composition containing midodrine or a pharmaceutically acceptable salt thereof as an active ingredient.La présente invention concerne une composition pharmaceutique pour la prévention ou le traitement de maladies associées à la cataracte diabétique, contenant de la mitodrine ou un sel pharmaceutiquement acceptable correspondant en tant que principe actif.본 발명은 미도드린(midodrine) 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는, 당뇨병성 백내장의 치료 또는 예방을 위한 약학적 조성물에 관한 것이다.
